Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity.
Saved in:
| Title: | Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity. |
|---|---|
| Authors: | Zamolodchikov D; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Duffield M; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Macdonald LE; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Alessandri-Haber N; Regeneron Pharmaceuticals, Tarrytown, New York, USA. |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2022 Oct; Vol. 18 (10), pp. 1919-1929. Date of Electronic Publication: 2022 Jan 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.12531 |
